Salivary Profiles of 11-oxygenated Androgens Follow a Diurnal Rhythm in Patients With Congenital Adrenal Hyperplasia

被引:8
|
作者
Nowotny, Hanna Franziska [1 ]
Auer, Matthias K. [1 ]
Lottspeich, Christian [1 ]
Schmidt, Heinrich [2 ]
Dubinski, Ilja [2 ]
Bidlingmaier, Martin [1 ]
Adaway, Jo [3 ]
Hawley, James [3 ]
Keevil, Brian [3 ]
Reisch, Nicole [1 ]
机构
[1] LMU Munchen, Klinikum Univ Munchen, Med Klin & Poliklin 4, D-80336 Munich, Germany
[2] LMU Munchen, Dr von Haunersches Childrens Hosp, Dept Pediat Endocrinol, Klinikum Univ Munchen, D-80336 Munich, Germany
[3] Manchester Univ Fdn NHS Trust, Manchester Acad Hlth Sci Ctr, Dept Clin Biochem, Manchester M23 9LT, Lancs, England
来源
关键词
congenital adrenal hyperplasia; saliva; diurnal rhythm; 11-ketotestosterone; 11-oxygenated androgens; STEROIDS; ANDROSTENEDIONE; 17-HYDROXYPROGESTERONE; PROGESTERONE; THERAPY; PLASMA; ADULT;
D O I
10.1210/clinem/dgab446
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Several studies have highlighted the importance of the 11-oxygenated 19-carbon (11oxC19) adrenal-derived steroids as potential biomarkers for monitoring patients with 21-hydroxylase deficiency (21OHD). Objective: To analyze circadian rhythmicity of 11oxC19 steroids in saliva profiles and evaluate their relevance as potential monitoring parameters in 21OHD. Design, Setting, and Participants: Cross-sectional single-center study including 59 patients with classic 21OHD (men=30; women=29) and 49 body mass index- and age-matched controls (men=19; women=30). Outcome Measures: Salivary concentrations of the following steroids were analyzed by liquid chromatography-tandem mass spectrometry: 17-hydroxyprogesterone (17OHP), androstenedione (A4), testosterone (T), 11 beta-hydroxyandrostenedione (11OHA4), and 11-ketotestosterone (11KT). Results: Similar to the previously described rhythmicity of 17OHP, 11-OHA4 and 11KT concentrations followed a distinct diurnal rhythm in both patients and controls with highest concentrations in the early morning and declining throughout the day (11OHA4: mean reduction of hormone concentrations between timepoint 1 and 5 (Delta(mean)) in male patients=66%; male controls Delta(mean)=83%; female patients Delta(mean)=47%; female controls Delta(mean)=86%; 11KT: male patients Delta(mean)=57%; male controls Delta(mean)=63%; female patients Delta(mean)=50%; female controls Delta(mean)=76%). Significant correlations between the area under the curve for 17OHP and 11KT (r(male)(p)=0.773(<0.0001); r(female)(p)=0.737(<0.0001)), and 11OHA4 (r(male)(p)=0.633(0.0002); r(female)(p)=0.564(0.0014)) were observed in patients but not present or reduced in controls. Conclusions: Adrenal 11oxC19 androgens are secreted following a diurnal pattern. This should be considered when evaluating their utility for monitoring treatment control.
引用
收藏
页码:E4509 / E4519
页数:11
相关论文
共 50 条
  • [31] GROWTH AND PUBERTAL DEVELOPMENT IN PATIENTS WITH CONGENITAL ADRENAL-HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY
    HOCHBERG, Z
    SCHECHTER, J
    BENDERLY, A
    LEIBERMAN, E
    ROSLER, A
    [J]. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1985, 139 (08): : 771 - 776
  • [32] DETERMINATION OF PLASMA 11-HYDROXYCORTICOSTEROID LEVEL IN PATIENTS ON INTERMITTENT HEMODIALYSIS DIURNAL RHYTHM, STIMULATION AND INHIBITION OF ADRENAL-CORTEX
    PICHLER, E
    ZIMMERMANN, E
    LOSKILL, D
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 1972, 84 (49) : 792 - +
  • [33] HORMONAL STUDIES IN OBLIGATE HETEROZYGOTES AND SIBLINGS OF PATIENTS WITH 11 BETA-HYDROXYLASE DEFICIENCY CONGENITAL ADRENAL-HYPERPLASIA
    PANG, S
    LEVINE, LS
    LORENZEN, F
    CHOW, D
    POLLACK, M
    DUPONT, B
    GENEL, M
    NEW, MI
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 50 (03): : 586 - 589
  • [34] Chimeric CYP11B2/CYP11B1 causing 11β-hydroxylase deficiency in Chinese patients with congenital adrenal hyperplasia
    Xu, Lingling
    Xia, Weibo
    Wu, Xueyan
    Wang, Xiaojing
    Zhao, Lili
    Nie, Min
    [J]. STEROIDS, 2015, 101 : 51 - 55
  • [35] A RARE CAUSE OF CONGENITAL ADRENAL HYPERPLASIA: CLINICAL AND GENETIC FINDINGS AND FOLLOW-UP OF SIX PATIENTS WITH 17 HYDROXYLASE DEFICIENCY
    Kardelen, Asli Derya
    Bas, Firdevs
    Toksoy, Guven
    Poyrazoglu, Sukran
    Bundak, Ruveyde
    Altunoglu, Umut
    Najafli, Adam
    Uyguner, Oya
    Darendeliler, Feyza
    [J]. HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 429 - 430
  • [36] CONGENITAL ADRENAL-HYPERPLASIA DUE TO 11 BETA-HYDROXYLASE DEFICIENCY - FINAL DIAGNOSIS IN ADULT AGE IN 3 PATIENTS
    GLENTHOJ, A
    NIELSEN, MD
    STARUP, J
    [J]. ACTA ENDOCRINOLOGICA, 1980, 93 (01): : 94 - 99
  • [37] CLINICAL AND BIOCHEMICAL VARIABILITY OF CONGENITAL ADRENAL-HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY - A STUDY OF 25 PATIENTS
    ZACHMANN, M
    TASSINARI, D
    PRADER, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 56 (02): : 222 - 229
  • [38] Effect of androgen excess and glucocorticoid exposure on metabolic risk profiles in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
    Paizoni, Luisa
    Auer, Matthias K.
    Schmidt, Heinrich
    Huebner, Angela
    Bidlingmaier, Martin
    Reisch, Nicole
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2020, 197
  • [39] THREE NOVEL CYP11B1 MUTATIONS IN MOROCCAN PATIENTS WITH CONGENITAL ADRENAL HYPERPLASIA DUE TO STEROID 11BETA-HYDROXYLASE DEFICIENCY
    Chabraoui, L.
    Abid, F.
    Menassa, R.
    Gaouzi, A.
    El Hessni, A.
    Morel, Y.
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S451 - S451
  • [40] Congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase type 11 deficiency in 4 Saudi children. Long term follow up
    Bin-Abbas, BS
    Sakati, NA
    Al-Ashwal, AA
    [J]. SAUDI MEDICAL JOURNAL, 2004, 25 (09) : 1293 - 1295